Category Archives: Industry: Healthcare

Healthcare is an ever evolving industry, and field. These Press Releases, will keep you up to date on the newest, greatest, best, solutions available.

Shift Labs Receives Small Business Innovation Research Phase II Award From US Air Force

[ad_1]

“We see this as an opportunity to transform and modernize a critical component of healthcare,” said Beth Kolko, Shift Labs CEO. “A connected DripAssist allows us to build a new data set that will dramatically improve insights into drug dosing and patient outcomes.”

Shift Labs, Inc., a Seattle-based company that designs and manufactures innovative, high-quality infusion technologies, announced today that it has been awarded a Phase II Small Business Innovation Research (SBIR) contract by the United States Air Force (USAF) through the AFWERX innovation program.

The Phase II contract will allow Shift Labs to develop wireless capabilities for the DripAssist Infusion Rate Monitor platform and integrate the device with patient monitoring and digital health solutions for both military and civilian customers.

DripAssist is the first monitored gravity infusion device that allows easy management of infusions without a conventional intravenous (IV) infusion pump. By adding data connectivity, the DripAssist platform will now capture and communicate previously unexplored data about treatments, patient response, and compliance related to medication delivery. Seamless integration of this data across multiple care sites will deliver key insights previously only available with complex equipment or expensive hospital visits.

Military healthcare providers regularly deliver gravity IV infusions throughout the care continuum and they need ways to improve data capture and information sharing, particularly during patient hand-offs. Outside of hospitals, civilian markets have the same problem; in homes, nursing facilities, or infusion suites, IVs are delivered via gravity or with pumps that lack real-time data sharing capability, meaning there is no easy way for distributed healthcare teams to monitor treatments. Accessing real-time IV infusion data is a key component of compliance and is especially crucial for health systems seeking to reduce rehospitalization for at-risk patient populations.

“We see this as an opportunity to transform and modernize a critical component of healthcare,” said Beth Kolko, Shift Labs CEO. “More and more IV medication is being delivered outside of hospitals, and surprisingly often this is via gravity infusion with little to no data captured. A connected DripAssist platform allows us to bring the power of data science to this growing healthcare segment and build a new data set that will dramatically improve insights into drug dosing and patient outcomes.”

While the Air Force is funding development of a wireless DripAssist to improve field care, Shift Labs is simultaneously developing the DripAssist technology to record gravity infusion data and share it to a multitude of civilian systems, including remote patient monitoring platforms, EHRs, infusion pharmacies, and clinical research organizations.

“We are excited to have the opportunity to pursue this dual-use technology and partner with organizations leading the charge to better understand how patients respond to treatment,” added Kolko. “Additional impact will come from our partnerships with Clinical Research Organizations as we explore how the DripAssist platform adds new layers of data to digital clinical trials and potentially improves drug discovery timelines.”

In a prior SBIR Phase I award, DripAssist was successfully evaluated as an effective tool to improve the administration of intravenous (IV) infusions in austere care settings such as field medicine, forward surgical teams, aerovac, and prolonged field care. DripAssist is already in use across environments as diverse as US home care to Ebola treatment centers.

About Shift Labs

Shift Labs, Inc. is a Seattle-based company that creates well-designed medical devices for fast-growing healthcare sectors, everywhere from alternate site care in the US to clinical care in emerging markets. The DripAssist Infusion Rate Monitor is their first product and has previously been recognized as one of Popular Science Magazine’s 12 Best Healthcare Innovations of 2016, as well as receiving the MedTech Conference’s 2017 Global Health Innovation Award, a Silver medal from the Industrial Designers Society of America IDEA awards, funding from USAID as part of the Ebola Grand Challenge and Saving Lives at Birth: A Grand Challenge for Development and a Phase 1 SBIR from the United States Air Force. Learn more at http://www.shiftlabs.com

About the Air Force Research Lab (AFRL) and AFWERX SBIR Program

AFRL and AFWERX have partnered to streamline the Small Business Innovation Research process in an attempt to speed up the experience, broaden the pool of potential applicants and decrease bureaucratic overhead. Beginning in SBIR 18.2, and now in 19.2, the Air Force has begun offering ‘Special’ SBIR topics that are faster, leaner and open to a broader range of innovations.

Inquiries:

Contact CEO Beth Kolko, beth@shiftlabs.com, or CTO Koji Intlekofer, koji@shiftlabs.com at +1 206.369.1216.

Share article on social media or email:

[ad_2]

Source link

The American College of Medical Toxicology Offers ‘Total Tox Course’ Cutting-Edge Toxicology for Healthcare Providers

[ad_1]

News Image

Emergency providers need to stay updated on med tox since the possibility of a hazmat event is a daily reality, drug overdose is the leading cause of death from injury in the US, and new issues, such as vaping-associated lung injury, continue to emerge.

ACMT will present the 2019 ‘Total Tox Course’ on Monday, December 9 – Wednesday, December 11, 2019, at The Wink Hotel in Washington, DC.

The ACMT Total Tox Course is a comprehensive review of the scope of emergency toxicology and will include up-to-date interventions and management options for poisoned patients. Prominent experts in medical toxicology and emergency medicine will lead the course.

The 3-day course will focus on medical toxicology topics of interest to physicians, mid-level practitioners, clinical pharmacists, paramedics and emergency providers, including issues of current clinical and public health importance. Attendees will be presented with the most up-to-date information to evaluate and manage cases of poisoning and exposure to medications, drugs of abuse, chemical terrorism, and environmental toxins.

Topics will include:


  • Dangers and Management of Opioid Abuse
  • Over-the-Counter Poisons
  • Carbon Monoxide Poisoning
  • Envenomations
  • Disaster Preparedness
  • Dangers in Your House
  • Tricyclic Antidepressants, Antipsychotics, SSRIs and Lithium
  • Ethanol Intoxication & Withdrawal
  • Plants, Mushrooms & Nutritional Supplements 
  • Toxic Alcohols
  • Antimicrobials & Antivirals
  • Drug Screen Pitfalls
  • Asphyxiants
  • Anticonvulsants
  • And More!

This activity is eligible for CME (Continue Medical Education) and CPE (Continuing Pharmacy Education).

Register for the course and reserve your hotel room by November 18, 2019 to get the ACMT early bird discount and the group rate at The Wink Hotel.

This course has been recommended by the American Academy of Emergency Medicine, The District of Columbia ACEP Chapter, and the Pennsylvania College of Emergency Physicians.

The American College of Medical Toxicology (ACMT) is a professional, nonprofit association of physicians with recognized expertise and board certification in medical toxicology. Our members specialize in the prevention, evaluation, treatment, and monitoring of injury and illness from exposures to drugs and chemicals, as well as biological and radiological agents. ACMT members work in clinical, academic, governmental, and public health settings, and provide poison control center leadership.

Share article on social media or email:

[ad_2]

Source link

The Conference Forum Announces Immuno-Oncology 360° (IO360°) Summit Early 2020 Keynotes and Notable Speakers

[ad_1]

IO360

What makes IO360° so important is that it joins cancer expertise from clinical, business, regulatory, academic and nonprofit communities together with the goal of advancing treatments to enable a patient’s immune system to eradicate cancer faster.

The Conference Forum has announced that the 6th annual IO360°: Immuno-Oncology 360° Summit will take place on February 26 – 28, 2020 at the Crowne Plaza Times Square Hotel in New York City, NY, with a full day dedicated to Cell & Gene Therapy for Solid Tumors on February 27.

The opening keynotes include IO pioneers and entrepreneurs, Carl June, MD, Director, Center for Cellular Immunotherapies at the Perelman School of Medicine; UPenn and Arie Belldegrun, MD, Executive Chair and Co-founder, Allogene who will address T-cell and CAR-T therapy advancements.

The most prestigious analyst in IO, Andrew Baum, MD, Head of Global Healthcare and Managing Director, Equity Research for Citi will deliver the financial opening keynote on the Evolution and Forecast of the IO Space.

Delivering a cornerstone presentation on New Scientific Frontiers in Cell Therapies for Solid Tumors will be immunotherapy expert Crystal Mackall, MD, Professor of Pediatrics and Medicine and Director of the Stanford Center for Cancer Cell Therapy at Stanford University School of Medicine.

Peter Marks, MD, PhD, Director of the Center for Biologics Evaluation and Research, FDA will be leading a panel discussion on the Evolution of Regulatory Policy for Cell & Gene Therapy.

Joining the program as the 2020 guest keynote is cancer veteran and advocate Jane Perlmutter, PhD, who will participate in a fireside chat to share her remarkable journey with immunotherapy.

New leadership to IO360° includes:


  • Charles Drake, MD, PhD, Columbia University Medical Center
  • Stephanie Goff, MD, National Cancer Institute
  • Stephan Grupp, MD, PhD, Children’s Hospital Of Pennsylvania (CHOP)
  • Ramy Ibrahim, MD, Parker Institute for Cancer Immunotherapy
  • Beth Metzheiser, BMS
  • Annette Schmid, MD, Takeda
  • Aiman Shalabi, PharmD, GSK
  • Martin Stumpe, PhD, Tempus
  • Roman Yelensky, PhD, Gritstone Oncology


Amongst many more

With more than 80 IO topics covered, IO360° is divided into the following plenaries with data presentations and panel discussions on Discovery and Preclinical Science, Translational Science, Clinical Developments, Bispecifics, Biomarkers and Diagnostics, Clinical Operations, AI for Cancer Immunotherapy, Imaging Aspects, Business Developments, and Emerging Technologies.

For the first time, IO360° 2020 features a day dedicated to Cell and Gene Therapy with a focus on solid tumors to take place on February 27. Chairing the Cell & Gene Therapy day will be Aiman Shalabi, PharmD, Vice President of R&D, Cell and Gene Therapies for GSK and will lead the program in addressing the following topics: Landscape and Evolution of the Cell & Gene Therapy Marketplace, New Scientific Frontiers in Cell Therapies for Solid Tumors, Cell Therapy Pivotal Pharma Developments for Solid Tumors, Current and Future Innovations Toward GMP Manufacturing of CAR and TCR Engineered T cells, FDA Led Session on the Evolution of Regulatory Policy for Cell & Gene Therapy, New Collaborative Development Paradigms for Cell Therapies and Cell & Gene Therapy Debates.

“Developing immuno-oncology treatments for patients that could become the standard of care across a wide variety of cancers is still a complex challenge,” said Kate Woda, Director, IO360°. “What makes IO360° so important is that it joins cancer expertise from clinical, business, regulatory, academic and nonprofit communities together with the goal of advancing treatments to enable a patient’s immune system to eradicate cancer faster.”

IO360° will also feature extensive networking opportunities and includes one-on-one partnering to help facilitate business meetings and additional collaborations.

To learn more please visit theconferenceforum.org

About Immuno-Oncology 360˚:

Immuno-Oncology (IO) 360° is the premier meeting across all stakeholders in IO, addressing the rapid advancements of clinical, scientific and business developments of IO in one setting to help develop therapeutics for a wider range of cancers at an accelerated rate. Guided by lead advisors Axel Hoos, MD, PhD, SVP of Oncology R&D, GSK, James Gulley, MD, PhD, Head of Immunotherapy Section and Director of Medical Oncology Service at the Office of the Clinical Director, Center for Cancer Research, NCI, Priti Hegde, MD, Chief Scientific Officer, Foundation Medicine, Andrew Baum, MD, Head of Global Healthcare and Managing Director, Equity Research, Citi, Dan Chen, MD, PhD, Chief Medical Officer, IGM Biosciences, Jacqueline Karmel, Principal International Scientific Director, Roche and Ian McCaffery, VP, Oncology Translational Science, Janssen. The three-day summit features ten plenary sessions, a dedicated day to Cell & Gene Therapy, over 120 speakers and more than ten hours of networking. There will be over 500 attendees representing pharma, biotechs, academia, research organizations, business development and the IO investment community.

About the Conference Forum:

The Conference Forum is a life science industry research firm that develops conferences primarily around how to get therapeutics to patients faster. They examine and challenge the complex ecosystem of drug development and delivery, bringing ideas together from a variety of sources to help advance clinical research with common goals that are patient-focused. They are committed to creating the best content, exchange of ideas and solutions among peers, as well as providing high quality networking.

[ad_2]

Source link

Global Call Forwarding partners with Allergan to improve call center support in Asia

[ad_1]

Allergan Partnership

Allergan and Global Call Forwarding Partnership

Allergan was able to significantly expand their global support coverage without seeing a drastic increase in operating costs.

Global Call Forwarding, a leading U.S. cloud communications provider, has announced its new partnership with Allergan to improve call center support in Asia using local DID phone numbers.

Allergan is a global pharmaceutical leader with commercial operations in more than 100 countries. It has a portfolio of leading brands that spans four key therapeutic areas: medical aesthetics, eye care, central nervous system, and gastroenterology.

Millions of people around the world rely on Allergan’s best-in-class products every day. Therefore, their ability to provide localized telephone support across international markets is crucial. However, Allergan’s telephone support operations are managed from centralized regional contact centers, which restricts their ability to provide local telephone support to their customers.

Their immediate requirement was to obtain local phone numbers in key markets, which forward the inbound calls to one of Allergan’s regional contact centers. Multinational companies in today’s hyper-connected digital economy are increasingly utilizing cloud contact center solutions like direct inward dial (DID) numbers to implement this solution.

According to the VP of Marketing and Sales at Global Call Forwarding, Bulent Erkaya, “Using direct inward dial numbers can be the most effective way to offer a local point of telephone contact in any foreign market. By integrating this solution, Allergan was able to significantly expand their global support coverage without seeing a drastic increase in operating costs. They activated DID numbers in many key markets, delivering much-needed telephone support and managing their operations from centralized contact centers.”

Companies with global sales and support operations are increasingly activating local phone numbers in countries where they need to offer telesupport. This makes it easier for international-based customers to contact these companies without paying for long-distance calls or dialing unfamiliar phone numbers.

Having a regional office in APAC for sales, support, and service delivery made Global Call Forwarding the ideal candidate for this partnership with Allergan.

In addition, Global Call Forwarding has the largest selection of local DID phone numbers in Asia. Their ability to provide phone numbers in unique, hard-to-get origination countries was also a major deciding factor.

By partnering with Global Call Forwarding, Allergan will increase worldwide access to customer support and improve call center reactivity while achieving significant cost savings.

This partnership will also strengthen the leading market position Global Call Forwarding holds, as it adds another major multinational corporation in the pharmaceutical sector to its clientele.

About Global Call Forwarding

Global Call Forwarding is owned and operated by United World Telecom, which has been serving companies with innovative telecommunications solutions since 1996. United World Telecom has rapidly expanded its global presence and service offerings in the last twenty-two years to offer international call forwarding, outbound calling, SMS forwarding, and call recording. Visit http://www.globalcallforwarding.com for more information.

Share article on social media or email:

[ad_2]

Source link

Alera Group Acquires Makro Enterprises

[ad_1]

News Image

The expertise of Scott Edlin and his team expands the regional offerings of Alera Group in Nevada. They are a strong expansion of our expertise in employee benefits, and we are excited to welcome them.

Alera Group, an independent national insurance brokerage and wealth management firm, today announced that it has acquired Makro Enterprises (Makro), effective September 1, 2019. Makro will join Alera Group through local firm GLB Insurance.

Makro offers employee benefits and insurance services for clients throughout Las Vegas and the surrounding region. Makro was formerly the insurance arm of ManagedPay, a Las Vegas payroll company.

“The expertise of Scott Edlin and his team expands the regional offerings of Alera Group in Nevada. They are a strong expansion of our expertise in employee benefits, and we are excited to welcome them to Alera Group,” said Alan Levitz, CEO of Alera Group.

“We are thrilled to join Alera Group and, locally, the GLB team,” said Scott Edlin, Managing Partner of Makro. “The national scope of resources will be hugely valuable as we continue to serve our clients with excellence, and we look forward to collaborating with other Alera Group firms across the country.”

The Makro service team will continue serving clients in their current roles. Additionally, all payroll services through ManagedPay will continue going forward through that organization. Terms of the transaction were not disclosed.

About Alera Group

Based in Deerfield, IL, Alera Group’s over 1,500 employees serve thousands of clients nationally in employee benefits, property and casualty, risk management and wealth management. Alera Group is the 15th largest independent insurance agency in the country. For more information, visit http://www.aleragroup.com or follow Alera Group on Twitter: @AleraGroupUS

Alera Group: Rob Lieblein, Chief Development Officer, 717-329-2451, rob.lieblein@aleragroup.com

Share article on social media or email:

[ad_2]

Source link

Packline Materials Handling Announce The Production Of The New Coffin Lifter Designed To Support And Rotate Coffins During Transportation

[ad_1]

The Coffin Lifter is the ideal solution to increase efficiency and improve health and safety conditions.

New to Packline Materials Handling, the Coffin Lifter is a bespoke attachment that is permanently mounted to a heavy-duty stacker truck. The Coffin Lifting attachment is designed to support and rotate coffins, up to 660lbs, when they need to be moved from one area to another. It is possible to slide the coffin away from the attachment and on to a shelf or stand as required.

There is a rotation function to re-orientate the coffin as desired. The front and rear rollers have a brake system which are knee operated to ensure that the coffin is secure while in transit.

The lifter has electric lift and is manually pushed along. Electric drive versions also available. The maximum lifting height for inserting the coffin into racking is 84” (2140mm). If the coffin is required to be rotated it should not exceed 39” (1000mm) high to ensure the stability of the truck.

The truck is fitted with counterbalance weights of 88lbs (40kg) to ensure stability. It is always recommended to ensure the heaviest end of the coffin sits closest to the lifter’s mast.

Technical Specification:

Safe Working Load = 661lbs (300kg)

Maximum roller pitch = 64” (1646mm)

Overall length when parallel with legs = 78” (2000mm)

Overall lifter length = 108” (2759mm)

Maximum lift height when parallel with legs = 84” (2140mm)

Maximum lift height at 90 degrees = 39” (1000mm)

The coffin lifting machine is backed up by a full bespoke design service so ensuring that the right solution can be made to suit most requirements. The design focuses on the safety and ergonomic working conditions of the operator.

Packline Materials Handling is a leading manufacturer and supplier of quality materials handling equipment for a wide range of industries worldwide.

Packline Materials Handling can provide bespoke lifting and handling solutions for most materials handling issues by creating new concepts or tailoring existing lifting and handling equipment to meet specific requirements.

Packline’s range of lifters and attachments are built to order allowing our sales team to ensure that you get the correct lifting and handling solution for your needs.

The company’s in-house design facility and workshop enables high quality and effective solutions to be realised within short lead times.

For further information on the Coffin Lifter, or the full range of lifting and handling equipment, please contact Packline Materials Handling.

Packline Ltd

Unit 28

Newtown Business Park

Ringwood Road

Poole, Dorset

BH12 3LL, UK

https://www.packline.co.uk/stacker-handling-coffins/

Share article on social media or email:

[ad_2]

Source link

Women’s Excellence Welcomes Dr. Caela Hesano, MD to Their Team

[ad_1]

News Image

Women’s Excellence is pleased to welcome Dr. Caela Hesano, MD to the team. Dr. Hesano is an understanding, caring and highly skilled Obstetrician/Gynecologist. She approaches patients compassionately and offers comprehensive obstetrical and gynecological care, including high-risk obstetrical medicine. Dr. Hesano strives to ensure that each visit is comfortable, patient-focused, and that every patient feels her concerns have been fully addressed.

Dr. Hesano practices evidence-based medicine and stays current with new changes and opportunities that may benefit her patients. She has a special interest in caring for adolescents and minimal invasive surgery, as well as treating endometriosis, chronic pelvic pain, abnormal uterine bleeding, and much more! Dr. Hesano specializes in a wide range of complex concerns including:


  • Endometriosis
  • Pelvic pain
  • Pelvic adhesions
  • Pelvic infections
  • Minimally invasive robotic surgery
  • Laparoscopic surgery
  • Ovarian cysts
  • Uterine fibroids
  • Uterine polyps
  • Abnormal uterine bleeding including heavy, irregular and/or painful periods
  • Pelvic organ prolapse
  • Hormonal irregularities
  • Menopause
  • Osteoporosis
  • Infertility
  • Genetic testing

“Caela is a dedicated obstetrician and gynecologist who is committed to patient care and advanced technologies in medicine. Her passion for women’s healthcare will benefit our patients immensely. We’re thrilled to have her on our team!” Dr. Jonathan Zaidan, MD, FACOG, President of Women’s Excellence

For more information or to schedule an appointment, visit http://www.WomensExcellence.com. Online Patient Support Specialists are available Monday through Friday from 8am-5pm to assist new, current, and prospective patients. The chat is located at the bottom right corner of your computer or mobile device screen at http://www.WomensExcellence.com. During offline hours, all chats sent will be messaged directly to a Women’s Excellence team member. Offline messages will receive a response within 24 hours. Messages received during the weekend will be answered the next business week.

Appointments can also be made at (248) 693-0543.

Women’s Excellence is the most comprehensive obstetric and gynecologic office in Michigan. Additionally, they specialize in menopause, weight control, bladder control, endometriosis, robotic surgery, oncology, and midwifery services. Women’s Excellence is committed to staying at the forefront of innovation with cutting edge technologies utilizing robotic surgery and minimally invasive surgical options when possible. The knowledgeable, compassionate physicians and healthcare providers of Women’s Excellence focus on patient-centered processes to deliver the highest quality of care. They are affiliated with most insurances. They offer seamless medical record access via a state-of-the-art patient portal and use the latest technology for record keeping and sharing, making the patient experience easier and more efficient. Women’s Excellence is taking new patients and is conveniently located throughout southeastern Michigan in Birmingham, Lake Orion, Clarkston, Rochester, Royal Oak, and West Bloomfield. Coming soon, Women’s Excellence will open in Lapeer, Michigan. For more information, visit http://www.WomensExcellence.com.

Share article on social media or email:

[ad_2]

Source link

Mediaplanet and Schoox Team up to Discuss the Importance of Connecting Learning and Performance in the Workplace

[ad_1]

News Image

“The cross-platform campaign advocates for an increased emphasis on overall employee health, engagement, and benefits.”

Using the expertise of industry leaders to explore solutions to problems facing the ever-changing corporate landscape, Mediaplanet today announces the launch of its September, open enrollment edition of their campaign, “Employee Benefits and Engagement.” With topics ranging from the importance of candid one-on-one conversations, ideas for improving wellness initiatives, investing in smoking cessation activities, how continuous learning and development for employees and management is key to employee engagement, to the importance of transparency around pay equity, the campaign shows how companies can thrive when they invest in the wellbeing and success of their employees.

The cross-platform campaign advocates for an increased emphasis on overall employee health, engagement, and benefits. By partnering with the HR industry’s most prominent thought leaders, the included stories highlight the importance for employers to expand employee benefits and development programs, implement HR efficiencies, and improve wellbeing solutions. Its ultimate aim is to help managers and HR professionals cultivate a happier, healthier, and more developed workforce, all while boosting company engagement, which improves retention and allows for the professional growth of top talent.

In the campaign, Matthew Brown, vice president of learning and brand success at Schoox, discusses the changes occurring in the workforce, like performance management shifting away from the point-in-time evaluations. In addition, he emphasizes the important connection between learning and performance, and why companies should be incorporating the two simultaneously. “The Brandon Hall Group reports that fewer than half of companies effectively link learning to performance. Yet, connecting the two provides a line of sight into employee skills, knowledge, and competency gaps. Companies are able to demonstrate their commitment to growth and career opportunities — increasing engagement, retention, and attracting more talent.” Read more here.

The print component of “Employee Benefits & Engagement” is distributed in today’s edition of USA Today New York, Los Angeles, Chicago, Houston, San Francisco, Las Vegas, Washington DC, Baltimore, and Philadelphia. In addition, it will be distributed at several industry-focused conferences, including the HERO Forum this weekend, SHRM Inclusion, ATD’s Core 4 Conference, HRSouthwest, the HR Technology Conference & Expo, WorldatWork 2020 Total Rewards Conference, and more. The digital component is distributed nationally, through a vast social media strategy, and across a network of top news sites and partner outlets. To explore the digital version of the campaign, click here.

This campaign was made possible with the support of the Society for Human Resource Management, WorldatWork, Health Enhancement Research Organization, National Alliance of Healthcare Purchaser Coalitions, Integrated Benefits Institute, Midwest Business Group on Health, Association for Talent Development, DallasHR, WELCOA, Human Resource Executive Magazine, National Business Group on Health, Human Resource Executive Magazine, Paychex, the American Heart Association, WorkPartners, CareerArc, Paragon Relocation Services, Vaxserve, DeVryWORKS, Desktime, Carrot.co, International Coach Federation, EE Incentives, Marketplace Chaplains, and Schoox.

About Mediaplanet

Mediaplanet specializes in the creation of content marketing campaigns covering a variety of industries. We tell meaningful stories that educate our audience and position our clients as solution providers. Our unique ability to pair the right leaders with the right readers, through the right platforms, has made Mediaplanet a global content marketing powerhouse. Our award-winning stories have won the hearts of countless readers while serving as a valuable platform for brands and their missions. Just call us storytellers with a purpose. Please visit http://www.mediaplanet.com for more on who we are and what we do.

Insert Press Contact:

Rebecca Levine

Rebecca.levine@mediaplanet.com

646-755-7966

Share article on social media or email:

[ad_2]

Source link

Invistics Awarded NIH Grant as Part of Initiative to Help End Addiction

[ad_1]

Invistics, the leading provider of advanced healthcare inventory visibility and analytics software, today announced that the National Institutes of Health (NIH) has awarded the company an additional supplementary grant to further expand its drug diversion program. The supplementary grant was awarded as part of the small business awards made through the NIH HEAL (Helping to End Addiction Long-Term) Initiative. NIH launched the HEAL Initiative in 2018 in an effort to address the national opioid crisis using scientific solutions. In total, NIH has granted Invistics over $2 million. NIH has also extended the research project timeline through November 2020.

Invistics’ drug diversion program currently leverages machine learning and advanced analytics to detect opioid and drug theft across nursing and pharmacy departments in hospitals and health systems. This second supplementary grant will help Invistics expand its program to cover anesthesiology departments, an area where drug diversion commonly occurs within hospitals.

“Drug theft continues to be an issue that jeopardizes patients and that affects all healthcare providers. With this grant, we plan to help hospitals and health systems get the resources they need to detect drug diversion in a matter of days instead of weeks,” said Tom Knight, founder and CEO of Invistics. “We’re grateful for the continued support of NIH as we work with hospitals to prevent and detect drug diversion, thus increasing patient safety and reducing financial risk.”

According to a recent survey, 98 percent of respondents believed that drug diversion negatively impacts patient care and compliance. An example of the negative impact of drug diversion includes a recent CDC report of a Hepatitis C outbreak that was caused by a nurse diverting opioids in Washington.

“This Hepatitis C outbreak is just the latest example of why we are working with hospitals to prevent and detect drug diversion – patient safety,” added Knight. “Many hospitals recognize the issue and are taking steps to increase patient safety, but often it is not enough.”

The National Institute on Drug Abuse (NIDA), part of NIH, awarded Invistics a grant for the first phase of its research in 2017.

Invistics’ drug detection software is currently available to all hospitals and health systems across the U.S. To learn more about the NIH research results and Invistics, visit https://www.invistics.com.

Research reported in this publication was supported by the National Institute on Drug Abuse, part of the National Institutes of Health, under Award Number 1R44DA044083-01. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

About Invistics

Invistics is the leading provider of cloud-based software solutions for healthcare inventory visibility, providing advanced analytics and actionable insights for hospitals and health systems who want to detect and prevent drug diversion. Invistics’ solution, called Flowlytics®, tracks the movement of drugs across the complex supply chain – from the time they are shipped from the wholesaler to a healthcare facility, then each time drugs are moved throughout the hospital and administered to patients.

Atlanta-based Invistics Corporation also provides inventory visibility for manufacturers, distributers, repackagers and controlled substance registrants, helping to reduce inventory costs and compliance risks within a single facility or across the extended enterprise. To learn more, visit https://www.invistics.com.

Share article on social media or email:

[ad_2]

Source link

WMS Software Developer Datex Releases Guide on Reducing Warehouse Costs

[ad_1]

Using technology to reduce warehousing costs

How to Use Technology to Reduce Warehouse Costs Guide

“Having higher warehouse costs can mean that a warehouse operator or third party logistics provider is less competitive and able to attract and retain business” explained Michael Armanious, Vice President of Sales and Marketing for Datex.

Warehouse management software developer Datex recently released a guide to help 3PLs, distributors and fulfillment warehouse operators reduce warehousing costs using technology. The guide explains the reasons why warehousing operations costs are rising and how technology can play a vital role in curbing costs. The guide is free with registration for immediate download.

The 70+ page guide includes actionable suggestions and covers topics such as:

1. Using technology produces cost savings, aids in eliminating errors and increasing productivity

2. How workarounds are costing your company money

3. How protecting your IT infrastructure helps keep costs under control

4. The importance of using warehouse technology in contract packaging and contract manufacturing warehouses

“Our team has been hearing from supply chain management professionals about their frustration in dealing with rising warehouse costs, the need for faster order processing and shipments and increasingly complex inventory management challenges. Having higher warehouse costs can mean that a warehouse operator or third party logistics provider is less competitive and able to attract and retain business. This year it is especially important to control warehouse costs due to increasing transportation and logistics costs. From truck driver shortages to the new IMO January 2020 regulations that will increase the cost of fuel used on ocean-going ships, supply chain costs are escalating” said Michael Armanious, Vice President of Sales and Marketing.

The Datex guide entitled “How to Use Technology to Reduce Warehouse Costs” is available for immediate download here.

About Datex

A Microsoft Gold Partner, Datex provides flexible, reliable supply chain technology solutions to help make businesses more profitable. In successful operation since 1978, Datex has helped companies operate more efficiently and productively. Datex can provide state-of-the-art technology including award winning Microsoft-based warehouse management software, mobile devices and services such as EDI and mobile device management. Specializing in white glove service, Datex support, software development, implementation, project management and sales services are provided exclusively by employees rather than outsourced to third party vendors. For more information, please contact Laura Olson, Director of Sales and Marketing at 727-400-3641.

Share article on social media or email:

[ad_2]

Source link